CE Ventures (CEIIF)
VC Fund
Hong Kong, Hong Kong
CE Ventures (CEIIF) is a VC fund in Hong Kong focused on Software and Analytics. CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.
- Total investments:
- 34
- Last investment:
- Lead investor:
- 35%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries CE Ventures (CEIIF) invests in
Stages CE Ventures (CEIIF) invests in
Countries CE Ventures (CEIIF) invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Series A
- $4M–$7M
- Series B
- $4M–$30M
- Series C
- $10M–$40M
Investment Focus
Industry
- Software 9 (26%)
- Analytics 6 (18%)
- Big Data 5 (15%)
- Enterprise Software 5 (15%)
- SaaS 4 (12%)
Stage
- Series B 8 (24%)
- Series A 7 (21%)
- Series C 5 (15%)
- Seed 4 (12%)
- Funding Round 3 (9%)
Country
- Israel 13 (38%)
- United States 8 (24%)
- India 1 (3%)
- United Kingdom 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Lionel KeHan Tan
Analyst
|
Analyst | Total investments: 0 | Find email | |
|
Tayman Kan
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
|
Ben Weiss
Managing Partner
|
Managing Partner | Total investments: 29 | Find email | |
|
Sharon Goldblatt
Associate
|
Associate | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
NirogStreet is a technology-enabled and doctor-led community commerce platform to streamline the supply chain of Ayurvedic services and medicine so that doctors are able to deliver better healthcare to their patients. | $4M / Series B / Dec 24, 2021 | |
|
|
DiA Imaging Analysis provides advanced AI-based ultrasound analysis smarter and accessible. It solves the two main challenges clinicians face when using ultrasound: acquiring the right image and automatically analyzing it, to find clinical abnormalities that today they are struggling to find visually. DiA's automated tools can be easily beadded to any ultrasound device or healthcare IT system, just like an App.The company holds FDA/CE Clearances for its cardiac toolbox, generating revenues and having thousands of users around the world. | $14M / Venture - Series Unknown / Aug 24, 2021 | |
|
|
Centrical’s orchestrated Employee-Centric Success Platform gives employees an AI-powered, personalized, and gamified experience that unifies real-time performance management, continuous feedback, microlearning, and employee engagement, while supporting managers with interactive coaching and managerial tools. The company has offices in New York,Ra'anana, Israel and London. For more information please visit www.centrical.com. | $32M / Series C / Mar 10, 2021 | |
|
|
Panoply.io is an end to end data management platform for Analytics on the cloud that automatically tailor fits itself towards your end needs. Panoply automates data management from source to analysis, streamlining analysts’ and data scientists’ time to value. They optimize your time, granting up to 80% more efficiency by eliminating the time miredon complex labor of data preparation and management of unruly digital data and infrastructure. Incorporating best of breed data technologies, including Amazon's Redshift, Panoply.io utilizes machine learning and natural language processing (NLP) to learn, model and automate the standard data management activities performed by data engineers, Analysts and data scientists, saving thousands of code lines and countless hours of debugging and research. | $10M / Series B / Oct 27, 2020 | |
|
|
Codefresh is a next-generation enterprise software delivery platform for cloud-native applications. We help you automate your GitOps workflows and advanced deployments such as Canary and Blue/Green and are the premium Argo enterprise solution. DevOps teams from GoodRx, Monday.com, Deloitte, and more depend on Codefresh to deploy their softwarein a safe and scalable manner. Codefresh can support any pipeline end-to-end. | $27M / Series C / Jun 29, 2020 | |
|
|
Glassbox develops an analytics platform designed to automatically record, index, and analyze digital interactions.Formerly Clarisite, it empowers organizations to manage and optimize the entire digital lifecycle of their web and mobile customers. Leveraging unparalleled big data, behavioral analytics, and record-replay capabilities, Glassboxenables enterprises to see not only what online and mobile customers are doing but also why they are doing it. Most importantly, Glassbox informs and facilitates action based on those insights that can lead to enhanced customer experience, decreased customer disputes, and improved regulatory compliance. Its solutions are used by medium to very large enterprises mostly in the financial services and insurance industries but are equally relevant to the needs of a wide range of verticals including healthcare, telecommunications, utilities, gambling, and business services.The company was founded by Yaron Gueta, Hanan Blumstein, and Yoav Schreiber in 2010 and is headquartered in London, England. | $40M / Series C / Apr 07, 2020 | |
|
|
WeedOut is a biotechnology company focusing on providing weed control solutions. The company’s goal is to reduce the need for toxic herbicides and higher herbicide doses. | $4M / Series A / Feb 20, 2020 | |
|
|
Aromyx has built a platform for the digital capture of scent and taste – including the EssenceChip™ taste and scent sensor – that puts the human olfactory and taste receptors onto a disposable biochip, with a digital readout.The Aromyx platform includes the Allegory software suite, AromaGraph family of visual analytics, recommendedtaste/scent recording standards, access to the growing Aromyx online database of taste and scent data and related machine-learning algorithms.Unlike chemical sensors or mass spectrometry, the Aromyx EssenceChip system shows the biochemical signals that a cup of coffee, a sniff of perfume or a glass of wine send to the brain, as mediated by the human nose and tongue. | $3M / Seed / Jun 26, 2019 | |
|
|
Appdome is the industry's first mobile integration as a service company. AppDome's flagship product, the AppFusion platform, provides mobile developers and enterprise mobility professionals the ability to quickly and easily integrate third-party functionality with mobile apps, eliminating development and connecting mobile services ondemand. The cloud-based service is the first of its kind, accelerates enterprise mobility projects, and allows multiple functions to be combined with a single app simultaneously.Visit at: https://appdome.com | Private Equity / Feb 12, 2019 | |
|
|
Today’s explosive data growth and rapidly expanding application workloads threaten to overwhelm datacenters, preventing organizations from harnessing AI/ML, 5G, big data analytics, IoT, and other modern applications they need to achieve their business goals.Accelerating these data-hungry, storage-intensive applications requires moreapplication speed, storage capacity, data efficiency, and scalability than most organizations can afford, no matter how many CPUs and SSDs they add, or how much they expand their datacenter footprint.Just as GPUs overcome processing inefficiencies to accelerate artificial intelligence and advanced analytics performance, the breakthrough Pliops Extreme Data Processor (XDP) overcomes storage inefficiencies to massively accelerate performance and dramatically reduce overall infrastructure costs for databases, analytics, and machine learning. Delivered on an easy-to-deploy, low-profile PCIe card, the Pliops XDP radically simplifies the way data is processed and flash storage is managed.The result is an exponential increase in performance, reliability, capacity, and efficiency— multiplying the effectiveness of organizations’ infrastructure investments. | $30M / Series B / Jan 30, 2019 | |
| See all 34 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does CE Ventures (CEIIF) invest in?
CE Ventures (CEIIF) invests primarily in Software, Analytics and Big Data startups, most often at Series B and Series A stage. Most of the 34 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is CE Ventures (CEIIF)'s check size?
CE Ventures (CEIIF) typically joins rounds of $4M–$7M at Series A, $4M–$30M at Series B and $10M–$40M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CE Ventures (CEIIF) participates in.
How do I contact CE Ventures (CEIIF)?
Public channels for CE Ventures (CEIIF) include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CE Ventures (CEIIF)?
The team at CE Ventures (CEIIF) includes Lionel KeHan Tan (Analyst), Tayman Kan (Managing Partner) and Ben Weiss (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!